Carcinogenesis Advance Access originally published online on November 19, 2005
Carcinogenesis 2006 27(4):708-716; doi:10.1093/carcin/bgi269
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Neurotensin receptor 1 gene activation by the Tcf/ß-catenin pathway is an early event in human colonic adenomas
INSERM U673–UPMC, 1 Department of Pathology, and 2 INSERM U732–UPMC, Hôpital Saint-Antoine, 184 Rue Du Faubourg Saint-Antoine, 75571 Paris Cedex 12, France, 3 The Laboratory of Experimental Cancerology, Ghent University Hospital, B-9000 Ghent, Belgium and 4 Ludwig Institute for Cancer Research, Parkville, Victoria 3050, Australia
* To whom correspondence should be addressed at: INSERM U673, Hôpital Saint-Antoine, Bâtiment Raoul Kourilsky, 184 Rue Du Faubourg St-Antoine, 75571 Paris Cedex 12, France. Tel: +33 1 49 28 46 69; Fax: +33 1 44 74 93 18; Email: forgez{at}st-antoine.inserm.fr
Alterations in the Wnt/APC (adenomatous polyposis coli) signalling pathway, resulting in ß-catenin/T cell factor (Tcf)-dependent transcriptional gene activation, are frequently detected in familial and sporadic colon cancers. The neuropeptide neurotensin (NT) is widely distributed in the gastrointestinal tract. Its proliferative and survival effects are mediated by a G-protein coupled receptor, the NT1 receptor. NT1 receptor is not expressed in normal colon epithelial cells, but is over expressed in a number of cancer cells and tissues suggesting a link to the outgrowth of human colon cancer. Our results demonstrate that the upregulation of NT1 receptor occurring in colon cancer is the result of Wnt/APC signalling pathway activation. We first established the functionality of the Tcf response element within the NT1 receptor promoter. Consequently, we observed the activation of NT1 receptor gene by agents causing ß-catenin cytosolic accumulation, as well as a strong decline of endogenous receptor when wt-APC was restored. At the cellular level, the re-establishment of wt-APC phenotype resulted in the impaired functionality of NT1 receptor, like the breakdown in NT-induced intracellular calcium mobilization and the loss of NT pro-invasive effect. We corroborated the Wnt/APC signalling pathway on the NT1 receptor promoter activation with human colon carcinogenesis, and showed that NT1 receptor gene activation was perfectly correlated with nuclear or cytoplasmic ß-catenin localization while NT1 receptor was absent when ß-catenin was localized at the cell–cell junction in early adenomas of patients with familial adenomatous polyposis, hereditary non-polyposis colorectal cancer and loss of heterozygosity tumours. In this report we establish a novel link in vitro between the Tcf/ß-catenin pathway and NT1 receptor promoter activation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. P. Prevost, M. O. Lonchampt, S. Holbeck, S. Attoub, D. Zaharevitz, M. Alley, J. Wright, M. C. Brezak, H. Coulomb, A. Savola, et al. Anticancer Activity of BIM-46174, a New Inhibitor of the Heterotrimeric G{alpha}/G{beta}{gamma} Protein Complex. Cancer Res., September 15, 2006; 66(18): 9227 - 9234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Souaze, S. Dupouy, V. Viardot-Foucault, E. Bruyneel, S. Attoub, C. Gespach, A. Gompel, and P. Forgez Expression of Neurotensin and NT1 Receptor in Human Breast Cancer: A Potential Role in Tumor Progression. Cancer Res., June 15, 2006; 66(12): 6243 - 6249. [Abstract] [Full Text] [PDF]
|
|